Phase I study of Pomolidomide, Bortezomib, and Dexamethasone (PVD) as First-Line treatment of AL Amyloidosis or Light Chain Deposition Disease
Administered By
Awarded By
Contributors
- Kang, Yubin Principal Investigator
Start/End
- June 1, 2014 - December 1, 2021